HEART INTERNATIONAL – VOLUME 13 ISSUE 1 – SUMMER 2019
We are delighted to welcome you to the Summer 2019 edition of Heart International. This is an especially important edition for us, as it is our first as the official journal of the Complex Cardiovascular Catheter Therapeutics: Advanced Endovascular and Coronary Intervention Global Summit (C3) conference. One of our Editors-in-Chief, Dr Magdi El-Omar, outlines this exciting new partnership, along with our acquisition of the journal and his plans for the future of the journal in his Letter from the Editor.
We hope you enjoy this edition, which includes a topical expert interview, reviews, original research and a case report. We welcome colleagues in the field to submit their work to our winter edition – visit our submission page for more details.
Enjoy!
Foreword
These are exciting times at Heart International. Our journal has seen some changes recently: Heart International is now being published by Touch Medical Media and I am delighted to work alongside Dr Rajesh Davé in the role of Editor-in-Chief. In this edition we include a letter that provides our personal introductions, along with the publishing […]
Expert Interview
The treatment of coronary bifurcation lesions remains a key clinical challenge in interventional cardiology. Short-term trials have shown benefits with a provisional, one-stent approach, and these findings have been supported by longer-term data when compared with intentional, up-front two-stent approaches.1,2 However, these broad observations do not translate to practical guidance for physicians who may need […]
Letter
Dear Colleagues, Welcome to the summer 2019 edition of Heart International. I am delighted to inform you that Heart International has now recommenced regular publication after a hiatus. Heart International has recently been acquired by Touch Medical Media and hosted on their touchCARDIO platform, alongside their additional cardiology resources. Touch Medical Media is a dynamic […]
Review
Atherosclerosis is a leading health problem worldwide, especially with an aging population and the increasing incidence of prediabetic and diabetic conditions. In addition to coronary artery disease (CAD) and stroke, peripheral arterial disease (PAD) is a major cause of disability. The use of endovascular treatment for symptomatic lower extremity atherosclerotic disease has increased and spread […]
Original Research
Rivaroxaban is a direct factor Xa inhibitor indicated to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation (AF), treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE). Furthermore, it is prescribed for risk reduction and prophylaxis for DVT and PE following hip or knee replacement surgery and […]
Case Report
During conventional angiography, implanted stents can be hard to identify. In order to improve visualisation of metallic struts, stent enhancement (SE) algorithms have been developed.1 This technique, now available in most angiographic devices, works by identifying the two markers of a balloon positioned inside the stent, assuming that those markers move in synchrony with the […]
Trending Topic
After decades of debate, patent foramen ovale (PFO) closure is now a well-established strategy to reduce recurrent stroke in patients aged 18–60 years who have had a PFO-associated stroke.1 Patients who underwent PFO closure continue to have a higher stroke risk than the general population. A recent study demonstrated a 2.1% higher stroke rate in the […]
Log into your Touch Account
Keep track of your clinical interests and newsletter subscriptions.
Sign up with an Email
Or use a .
Register now for FREE access
Already registered? Login below.
